AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the Company will present a corporate overview and participate in one-on-one investor meetings during the H.C. Wainwright 25th Annual Global Investment Conference, taking place virtually and in-person at the Lotte New York Palace Hotel in New York City on September 11-13, 2023.
AC Immune’s corporate presentation will be available on-demand on Monday, September 11th at 7:00 am (EDT) / 1:00 pm (CEST) via the conference platform.
Please contact your H.C. Wainwright representative to request a meeting with AC Immune’s management team at the conference.